Analysts Anticipate Sharps Compliance Corp. (NASDAQ:SMED) Will Announce Quarterly Sales of $16.44 Million

Wall Street brokerages expect Sharps Compliance Corp. (NASDAQ:SMEDGet Rating) to report sales of $16.44 million for the current quarter, Zacks reports. Three analysts have made estimates for Sharps Compliance’s earnings, with the highest sales estimate coming in at $17.81 million and the lowest estimate coming in at $15.60 million. Sharps Compliance reported sales of $18.73 million in the same quarter last year, which indicates a negative year over year growth rate of 12.2%. The company is scheduled to announce its next earnings results on Monday, January 1st.

According to Zacks, analysts expect that Sharps Compliance will report full-year sales of $66.10 million for the current fiscal year, with estimates ranging from $65.90 million to $66.20 million. For the next fiscal year, analysts expect that the company will report sales of $68.49 million, with estimates ranging from $67.10 million to $69.20 million. Zacks Investment Research’s sales averages are an average based on a survey of analysts that follow Sharps Compliance.

Sharps Compliance (NASDAQ:SMEDGet Rating) last issued its quarterly earnings data on Wednesday, May 11th. The industrial products company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.05). Sharps Compliance had a return on equity of 5.44% and a net margin of 7.88%. During the same quarter in the previous year, the company earned $0.40 EPS.

Several analysts have recently weighed in on SMED shares. Zacks Investment Research raised shares of Sharps Compliance from a “sell” rating to a “hold” rating in a report on Tuesday, May 3rd. StockNews.com started coverage on shares of Sharps Compliance in a report on Thursday, March 31st. They issued a “hold” rating on the stock. Finally, Roth Capital downgraded shares of Sharps Compliance from a “buy” rating to a “neutral” rating and lowered their target price for the company from $12.00 to $7.00 in a report on Tuesday, April 5th. Five equities research analysts have rated the stock with a hold rating, According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $8.83.

Several large investors have recently modified their holdings of SMED. Citigroup Inc. lifted its stake in shares of Sharps Compliance by 228.8% in the fourth quarter. Citigroup Inc. now owns 5,544 shares of the industrial products company’s stock valued at $40,000 after purchasing an additional 3,858 shares during the period. Jane Street Group LLC acquired a new stake in shares of Sharps Compliance in the first quarter valued at about $59,000. Royal Bank of Canada lifted its stake in shares of Sharps Compliance by 552.0% in the third quarter. Royal Bank of Canada now owns 7,804 shares of the industrial products company’s stock valued at $65,000 after purchasing an additional 6,607 shares during the period. Capital Advisors Inc. OK acquired a new stake in shares of Sharps Compliance in the first quarter valued at about $70,000. Finally, California State Teachers Retirement System lifted its stake in shares of Sharps Compliance by 32.0% in the fourth quarter. California State Teachers Retirement System now owns 10,133 shares of the industrial products company’s stock valued at $72,000 after purchasing an additional 2,454 shares during the period. 56.06% of the stock is currently owned by institutional investors and hedge funds.

Shares of Sharps Compliance stock opened at $4.10 on Friday. Sharps Compliance has a 1 year low of $3.82 and a 1 year high of $17.05. The company has a debt-to-equity ratio of 0.06, a quick ratio of 3.03 and a current ratio of 3.50. The company has a market capitalization of $79.66 million and a P/E ratio of 13.23. The company’s fifty day moving average is $4.92 and its two-hundred day moving average is $6.22.

Sharps Compliance Company Profile (Get Rating)

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste generated outside the hospital and health care facility settings; TakeAway Recovery System to treat used needles, syringes, and other used healthcare products; Route-Based Pickup Service, a medical and hazardous waste pick-up services; and MedSafe, a solution for the safe collection, transportation, and disposal of unwanted and expired ultimate-user medications.

Featured Stories

Get a free copy of the Zacks research report on Sharps Compliance (SMED)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.